vl9 peptide Rh67 VL9 peptide - os-01-peptide-products VL9 peptides contain a highly conserved position 3 A residue The Crucial Role of the VL9 Peptide in HLA-E Function and Immune Regulation

os-01-peptide-review The VL9 peptide plays a pivotal role in the immune system, particularly in its interaction with HLA-E. HLA-E is a nonclassical, nonpolymorphic, class Ib HLA molecule whose primary function is to present a conserved nonamer peptide, commonly referred to as the VL9 peptideVL9, RT, (346-354). This interaction is essential for regulating natural killer (NK) cells and other immune responses. Understanding the intricacies of VL9 peptides and their binding to HLA-E is crucial for comprehending immune surveillance and developing novel therapeutic strategies.

HLA-E binds VL9 peptides, which are typically derived from the leader sequences of classical MHC class I molecules. These VL9 peptides have a highly conserved motif and are collectively known as MHC class Ia signal peptides (VL9). The binding of these peptides to HLA-E is critical for stabilizing HLA-E surface expression. Research indicates that VL9 peptide increases HLA-E surface expression primarily by promoting export from the Endoplasmic Reticulum (ER). This ER export is a key step in ensuring that HLA-E is correctly trafficked and presented on the cell surface.

The VL9 peptide itself is generated within the Endoplasmic Reticulum (ER) from nascent classical HLA-I molecules through proteolytic activity. While some VL9 peptides are derived from classical MHC (Ia) signal sequences, others, such as the Rh67 VL9 peptide, can also be processed and presented.作者：Z Hannoun·2018·被引用次数：46—These longerpeptidesrequired much higher concentrations thanVL9to stabilize HLA-E on the cell surface. Unexpected MHC-E involvement was ... Interestingly, CMV VL9 peptides can replace VL9 peptides derived from classical MHC (Ia) signal sequences, particularly when CMV disrupts antigen processing and presentation. This highlights the adaptability of the immune system and the diverse origins of peptides that can interact with HLA-EIdentification of novel HIV-1-derived HLA-E-binding peptides.

A significant aspect of VL9 peptide interaction with HLA-E is its role in immune cell recognition. HLA-E-VL9 complexes interact with natural killer (NK) cell receptors, specifically the heterodimeric inhibitory CD94-NKG2A and activating CD94-NKG2C receptors作者：BD Huisman·2023·被引用次数：40—Beyond the canonical MHC-I-derived peptide ligands, which share a highly conserved motif and are collectively referred to asVL9 peptides, .... This interaction is fundamental to NK cell-mediated cytotoxicity, acting as a checkpoint mechanism作者：MN Quastel·2026—HLA-E VL9 surface presentationconsequently reflects the functional status of the cellular MHC class I peptide presentation system, allowing NK.. When HLA-E presents VL9 peptides, it can signal to NK cells to either inhibit their cytotoxic activity or, in certain contexts, enhance it.Intracellular trafficking of HLA-E and its regulation - PMC - NIH

Furthermore, VL9 peptide-bound HLA-E complexes serve as major ligands for these NKG2A/CD94 receptors. This binding influences the functional status of the cellular MHC class I peptide presentation system and consequently impacts NK cell activityHLA-E/peptide complexes differentially interact with NKG2A .... The VL9 peptide is also known to be HLA-A2 restricted, optimal CTL epitope, suggesting its involvement in T cell responses as well.

The importance of VL9 peptides extends to their role in pathogen recognition. Besides self-peptides, HLA-E can also bind and present pathogen-derived peptides that are conformationally similar to VL9 peptides作者：JK Hwang·2025·被引用次数：2—HLA-E-VL9 was found to be expressed on HIV-infected cells, and its engagement by HLA-E-VL9 antibodies eliminated infected cells by NK-mediated .... This allows the immune system to recognize infected cells. For instance, HLA-E-VL9 was found to be expressed on HIV-infected cells, and engagement by specific antibodies could eliminate these infected cells via NK-mediated cytotoxicity. This underscores the potential of targeting HLA-E-VL9 interactions for therapeutic interventions against infectious diseasesHLA-C.

In the absence of VL9, peptides bound to HLA-E can be highly diverse and derived from self-proteins, lacking an obvious binding motif. However, the presence of canonical VL9 peptides ensures a more consistent and regulated presentation of information to immune cells.HLA-E-VL9 antibodies enhance NK cell and CD8 + ... - PubMed Studies have also shown that VL9 peptides contain a highly conserved position 3 A residue, which projects into a specific pocket, further defining their binding characteristics to HLA-E.

Research into HLA-E-VL9 antibodies has shown promise in enhancing NK cell and CD8+ T cell responsesHLA-C. These antibodies can potentially be used to overcome immune evasion mechanisms employed by tumors or pathogensMouse and human antibodies bind HLA-E-leader peptide .... For example, a high-affinity monoclonal antibody against HLA-E-VL9 has been shown to enhance natural killer cell anti-tumor killing through checkpoint inhibition and antibody-dependent cellular cytotoxicity.

The study of HLA-E-VL9 complexes also involves detailed structural analysis.Primary and secondary functions of HLA-E are determined ... For HLA-E-VL9, there is concordance between SAXS and crystal parameters, providing insights into their molecular arrangementMouse and human antibodies bind HLA-E-leader peptide .... In contrast, HLA-E-bound pathogen-derived peptides can produce larger SAXS dimensions, suggesting conformational differencesAntibodies that target hla-e-host peptide complexes and ....

In summary, the VL9 peptide is a critical component of the immune system, acting as a key ligand for HLA-E. Its ability to stabilize HLA-E surface expression, interact with NK cell receptors, and potentially present pathogen-derived peptides makes it a central player in immune regulation. Continued research into the diverse roles and interactions of VL9 peptides holds significant potential for advancing our understanding of immunology and developing novel therapeutic strategies2022年4月13日—Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A + NK cell line..